Phuong Khanh Morrow

Chief Medical Officer, CRISPR Therapeutics.

Companies

Lantheus Holdings, Inc.Board member Feb 7, 2025 to now¹
CRISPR TherapeuticsChief Medical Officer May 23, 2022 to Oct 17, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lantheus Holdings, Inc. LNTH7,237 shares³$723.9K at $100.03May 14, 2026
CRISPR Therapeutics CRSP4,411 shares⁴$220.2K at $49.91May 24, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 14, 2026Granted 4,137 shares of Lantheus Holdings, Inc.³
May 14, 2025Granted 2,537 shares of Lantheus Holdings, Inc.⁵
Feb 7, 2025Granted 563 shares of Lantheus Holdings, Inc.⁶
May 24, 2023Shares withheld for tax 2,527 shares at $65.91 of CRISPR Therapeutics⁴
May 23, 2023Exercised options 6,938 shares of CRISPR Therapeutics⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLantheus Holdings, Inc., Board member
2
SEC EDGARCRISPR Therapeutics, Chief Medical Officer
3
SEC EDGARLantheus Holdings, Inc. shares after the filing of May 14, 2026
4
SEC EDGARCRISPR Therapeutics shares after the filing of May 24, 2023
5
SEC EDGARForm 4 filed May 16, 2025
6
SEC EDGARForm 4 filed Feb 11, 2025